Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-16-019847
Filing Date
2016-08-12
Accepted
2016-08-12 17:24:15
Documents
12

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2829464
2 GRAPHIC g183927g21w10.jpg GRAPHIC 33374
3 GRAPHIC g183927g28n12.jpg GRAPHIC 47260
4 GRAPHIC g183927g42b53.jpg GRAPHIC 52782
5 GRAPHIC g183927g46v89.jpg GRAPHIC 105238
6 GRAPHIC g183927g50u51.jpg GRAPHIC 42520
7 GRAPHIC g183927g77f17.jpg GRAPHIC 84416
8 GRAPHIC g183927g80c75.jpg GRAPHIC 52173
9 GRAPHIC g183927g84b16.jpg GRAPHIC 34581
10 GRAPHIC g183927g87t50.jpg GRAPHIC 104996
11 GRAPHIC g183927g89g09.jpg GRAPHIC 49389
12 filename12.htm COVER 54673
  Complete submission text file 0000950123-16-019847.txt   3718418
Mailing Address AESCHENVORSTADT 36 BASEL V8 4051
Business Address AESCHENVORSTADT 36 BASEL V8 4051 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

EIN.: 473173478 | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-01325 | Film No.: 161829239
SIC: 2836 Biological Products, (No Diagnostic Substances)